MedPath

湖南明瑞制药股份有限公司

Ownership
-
Established
1992-08-04
Employees
-
Market Cap
-
Website
www.mrpc.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

Policresulen Solution

Product Name
聚甲酚磺醛溶液
Approval Number
国药准字H20253193
Approval Date
Jan 14, 2025
NMPA

Avatrombopag Maleate Tablets

Product Name
马来酸阿伐曲泊帕片
Approval Number
国药准字H20253117
Approval Date
Jan 8, 2025
NMPA

Lanthanum Carbonate Granules

Product Name
碳酸镧颗粒
Approval Number
国药准字H20249817
Approval Date
Dec 25, 2024
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20249733
Approval Date
Dec 17, 2024
NMPA

Iron Proteinsuccinylate Oral Solution

Product Name
蛋白琥珀酸铁口服溶液
Approval Number
国药准字H20244863
Approval Date
Sep 10, 2024
NMPA

Pediatric Compound Paracetamol and Amantadine Hydrochloride Tablets

Product Name
小儿复方氨酚烷胺片
Approval Number
国药准字H43021998
Approval Date
Aug 9, 2024
NMPA

Methenamine Hippurate Tablets

Product Name
马尿酸乌洛托品片
Approval Number
国药准字H10930055
Approval Date
Aug 7, 2024
NMPA

Compound Paracetamol and Amantadine Hydrochloride Tablets

Product Name
复方氨酚烷胺片
Approval Number
国药准字H43022066
Approval Date
Jul 9, 2024
NMPA

Aciclovir Tablets

Product Name
阿昔洛韦片
Approval Number
国药准字H43020094
Approval Date
Jul 3, 2024
NMPA

Tinidazole Tablets

Product Name
替硝唑片
Approval Number
国药准字H43020095
Approval Date
Jun 24, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.